Relevant identified uses of the substance or mixture and uses advised against

Similar documents
Product identifier Product Name Caladryl Clear Relevant identified uses of the substance or mixture and uses advised against

UN GHS According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

UN GHS According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

Purpose Gentle Cleansing Wash. Relevant identified uses of the substance or mixture and uses advised against

UN GHS According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

Relevant identified uses of the substance or mixture and uses advised against

Fog Shield XP 77; 8577; 8577PMT; FCP-4261 Dilute solvent and surfactant solution.

Vasotec tablets (2.5 mg 20 mg) Relevant identified uses of the substance or mixture and uses advised against

UN GHS According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

Section 1: Identification of the Substance/Mixture and of the Company/Undertaking

Section 1: Identification of the Substance/Mixture and of the Company/Undertaking

Sight Savers brand Anti Fog Liquid. Relevant identified uses of the substance or mixture and uses advised against

MATERIAL SAFETY DATA SHEET Issue Date: June 27, 2018

UN GHS According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

SECTION 1: Identification. SECTION 2: Hazard(s) identification Identification

SAFETY DATA SHEET 10X SDS Shearing Buffer D2

UN GHS According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

Safety Data Sheet (SDS)

Cardizem CD Capsules ( mg) Relevant identified uses of the substance or mixture and uses advised against

Section 1: Identification of the Substance/Mixture and of the Company/Undertaking

SAFETY DATA SHEET Sodium Phosphate Stock Solution (500 mm, ph 6.0)

NPK Fertilizer SAFETY DATA SHEET (SDS) OSHA Haz Com Standard 29 CFR Prepared to GHS Rev03.

SAFETY DATA SHEET Sodium Phosphate Assay Buffer. Section 2. Hazards Identification

Section 2: Hazard Identification UN GHS According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

MATERIAL SAFETY DATA SHEET Issue Date: June 28, 2018

AVANTI POLAR LIPIDS SAFETY DATA SHEET Page 1 of 6

SAFETY DATA SHEET Sodium Phosphate Stock Solution (500 mm, ph 8.0)

: Sweat Controls for Cystic Fibrosis Testing

Sight Savers brand Anti Fog Liquid Without Silicone. Relevant identified uses of the substance or mixture and uses advised against

UN GHS According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

Safety Cleaning Wipes MATERIAL SAFETY DATA SHEET. Section 1: CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

Use only for the purpose on the product label.

RINSE ALL. Restrictions on Use None known. Manufacturer Esteam Mfg Ltd, th NE, Calgary, Alberta, T2E6V2, , esteam.

Section 1: Identification of the Substance/Mixture and of the Company/Undertaking

Version 0.1 Revision Date 06/02/2015 Print Date 06/02/2015

SAFETY DATA SHEET. Section 1. IDENTIFICATION

SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

: TheraCal LC. SECTION 1: Identification. SECTION 2: Hazard(s) identification Identification Recommended use and restrictions on use

: Whitecap Contractor Strength

: Messy Pet Allergen Blocker

FERTILIZER. Safety Data Sheet. OSHA Haz Com Standard 29 CFR V Kraft Rd Lakeland, FL

SAFETY DATA SHEET CD34 Monoclonal FITC Antibody (Clone ICO-115)

Proteinase K Solution

: ARGININE HYDROCHLORIDE CRS

: Attraction Purely Pink

Essential oils,sandalwood (cas ) MSDS

Conforms to OSHA HazCom 2012 Standard and WHMIS SAFETY DATA SHEET. Section 1: IDENTIFICATION Piedmont Road, Suite 1300 Atlanta, GA 30329

Section 1: Identification of the Substance/Mixture and of the Company/Undertaking

: #1 Gray. Safety Data Sheet SECTION 1: IDENTIFICATION SECTION 2: HAZARDS IDENTIFICATION SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS

PreserVision AREDS 2 + Multivitamin. Relevant identified uses of the substance or mixture and uses advised against

SAFETY DATA SHEET CD4 Monoclonal FITC Antibody (Clone RIV7)

SAFETY DATA SHEET (Globally Harmonized System)

Collyrium Eye Wash Solution MATERIAL SAFETY DATA SHEET. Section 1: CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

SASE SFS SPR3. Safety Data Sheet. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

: LISINOPRIL DIHYDRATE CRS

ReNu MultiPlus Multi-Purpose Solution MATERIAL SAFETY DATA SHEET. Section 1: CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

MATERIAL SAFETY DATA SHEET

: RIZATRIPTAN BENZOATE CRS

SAFETY DATA SHEET. Natural Guard Neem RTU. Effective Date: 23-Mar PRODUCT AND COMPANY IDENTIFICATION

SAFETY DATA SHEET TR-FRET Assay Buffer (10X) Section 2. Hazards Identification

Safety Data Sheet Blue Buffer (RTU)

Use only for the purpose on the product label.

: MEPROBAMATE CRS. Safety Data Sheet Safety Data Sheet in accordance with Regulation (EC) No. 1907/2006, as amended.

3.1. Substances Not applicable 3.2. Mixtures Name Product identifier % 1,3,4-Thiadiazole, 2,5-bis(octyldithio)- (CAS-No.)

Whyte Gate, Inc. SAFETY DATA SHEET

Section 2: Hazard Identification UN GHS According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS)

: GLYCEROL FORMAL CRS

Safety Data Sheet. Zinc Benzoate Zinc Benzoate. Section 1 - Chemical Product and Company Identification. Section 2 - Hazards Identification

: FLUVASTATIN SODIUM CRS

SAFETY DATA SHEET (SDS)

H320 - Causes eye irritation H335 - May cause respiratory irritation

: POLYSHIM II.090X.375-1/16 SHIM 1000FT/CS

Section 1: Identification of the Substance/Mixture and of the Company/Undertaking

SAFETY DATA SHEET (SDS)

Safety Data Sheet - Version 5.0 Preparation Date 8/17/2016 Latest Revision Date (If Revised) SDS Expiry Date 8/16/2019

OIL, CINNAMON STICKS*

: BENZYL ALCOHOL CRS

: TRIAMCINOLONE HEXACETONIDE CRS

: Esomeprazole Sodium for Injection

: POVIDONE IODINATED CRS

Safety Data Sheet Safety Data Sheet in accordance with Regulation (EC) No. 1907/2006, as amended.

: Penetreat. SECTION 1: Identification of the substance/mixture and of the company/undertaking. SECTION 2: Hazards identification

OASIS PRO CITRUS GINGER ROOM REFRESHER. Use only for the purpose on the product label.

Safety Data Sheet acc. to OSHA HCS. Printing date 07/09/2015 Reviewed on 05/22/2015

: Aquamira Water Treatment Part B

SAFETY DATA SHEET CD34 Monoclonal Antibody (Clone ICO-115)

: Ampicillin for Injection

Material Safety Data Sheet

: SALBUTAMOL SULFATE CRS

SAFETY DATA SHEET Histone H4 Polyclonal Antibody

Transcription:

Safety Data Sheet Section 1: Identification Product identifier Product Name CeraVe Sunscreen Face Lotion SPF 30 Product Code 30 170PQ; 301872210017 Relevant identified uses of the substance or mixture and uses advised against Recommended use Sunscreen Details of the supplier of the safety data sheet Manufacturer Valeant Pharmaceuticals North America, LLC 400 Somerset Corporate Blvd. Bridgewater, NJ 08807 United States valeant.com Telephone (General) 1 800 321 4576 Emergency telephone number Manufacturer Manufacturer 1 800 535 5053 US Infotrac +1 352 323 3500 International Infotrac This safety data sheet is written to provide health, safety and environmental information for people handling this formulated product in the workplace. It is not intended to provide information relevant to consumer use of the product. Section 2: Hazard Identification According to: UN Globally Harmonized System of Classification and Labelling of Chemicals (GHS) Classification of the substance or mixture Eye Mild Irritation 2B Label elements WARNING Hazard statements May cause eye irritation Precautionary statements Prevention Use personal protective equipment as required. Wash thoroughly after handling. Response IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. Storage/Disposal Keep tightly closed. Store at room temperature 20 25ºC (68 77ºF), to maintain product integrity. Use before date marked on carton and/or container. Other hazards Page 1 of 16

Section 3 Composition/Information on Ingredients Substances Mixtures Material does not meet the criteria of a substance according to United Nations Globally Harmonized System of Classification and Labelling of Chemicals (GHS) Composition Chemical Name Identifiers % Classifications According to Regulation/Directive Aluminum oxide, hydrate CAS:1333 84 2 N/A : NDA Arachidyl alcohol CAS:629 96 9 EINECS:211 119 N/A : NDA 4 Arachidyl glucoside CAS:39825 93 9 EINECS:254 647 N/A : NDA 0 Avena sativa (oat) kernel extract CAS:84012 26 0 EINECS:281 672 N/A : Classification criteria not met 4 Beeswax CAS:8012 89 3 EINECS:232 383 N/A : Classification criteria not met 7 Behenyl alcohol CAS:661 19 8 EINECS:211 546 N/A : NDA 6 Benzyl alcohol CAS:100 51 6 EINECS:202 859 N/A : Acute Tox. Oral 4; Acute Tox. Inhal. 4 9 BHT CAS:128 37 0 EINECS:204 881 N/A : Skin Irrit. 2; Eye Irrit. 2A; Acute Tox. Oral 4 4 Bisabolol CAS:23089 26 1 EINECS:245 423 N/A : NDA 3 Butylene glycol CAS:107 88 0 EINECS:203 529 N/A : NDA 7 butyloctyl salicylate CAS:190085 41 7 N/A : NDA Carbomer CAS:9003 01 4 N/A : NDA ceramides CAS:100403 19 8 EINECS:309 560 N/A : NDA 3 Cetyl Dimethicone CAS:191044 49 2 N/A : NDA CAS:57 88 5 Page 2 of 16

Cholesterol EINECS:200 353 N/A : Skin Irrit. 2; Eye Irrit. 2A; Carc. 1A 2 Dimethicone CAS:63148 62 9 N/A : NDA Dimethicone PEG 8 Laurate CAS:35179 86 3 N/A : NDA Dipotassium Glycyrrhizate CAS:68797 35 3 EINECS:272 296 N/A : NDA 1 EDTA CAS:139 33 3 EINECS:205 358 N/A : NDA 3 Ethylhexylglycerin CAS:70445 33 9 N/A : Eye Dam. 1 Glycerin CAS:56 81 5 EINECS:200 289 N/A : Skin Irrit. 3; Eye Irrit. 2B 5 Glyceryl stearate CAS:31566 31 1 EINECS:250 705 4 N/A : NDA Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer isohexadecane L Ascorbic acid CAS:111286 86 3 CAS:4390 04 9 EINECS:224 506 8 CAS:50 81 7 EINECS:200 066 2 N/A N/A N/A : NDA : NDA : Skin Corr. 1; Skin Irrit. 2; Eye Dam. 1; Eye Irrit. 2A Methicone CAS:63148 57 2 N/A : Eye Irrit. 2A Methylisothiazolinone CAS:2682 20 4 EINECS:220 239 N/A : NDA 6 Niacinamide CAS:98 92 0 EINECS:202 713 N/A : NDA 4 Pantothenic acid CAS:79 83 4 EINECS:201 229 N/A : NDA 0 PEG 100 stearate CAS:9004 99 3 N/A : NDA PEG 8 CAS:25322 68 3 N/A : Skin Irrit. 3; Eye Irrit. 2B; Acute Tox. Oral 4 Phytosphingosine CAS:13552 11 9 N/A : NDA Polyaminopropyl biguanide CAS:133029 32 0 N/A : NDA Polyhydroxystearic acid CAS:27924 99 8 N/A : NDA Polymethyl methacrylate CAS:9011 14 7 N/A : NDA Polysorbate 60 CAS:9005 67 8 N/A : NDA Potassium sorbate CAS:24634 61 5 EINECS:246 376 N/A : NDA 1 Retinyl palmitate CAS:57 10 3 EINECS:200 312 N/A : Skin Irrit. 2; Eye Irrit. 2A 9 Silica CAS:7631 86 9 EINECS:231 545 N/A : Eye Irrit. 2A 4 Sodium Lauroyl Lactylate CAS:13557 75 0 EINECS:236 942 6 N/A : NDA Page 3 of 16

Stearic acid CAS:57 11 4 EINECS:200 313 4 N/A : Skin Irrit. 2; Eye Irrit. 2A; Muta. 1; Carc. 1A; Repr. 1 Styrene/Acrylates Copolymer CAS:25034 86 0 N/A : NDA Titanium dioxide CAS:13463 67 7 EINECS:236 675 3.7% : STOT RE 2; Carc. 2 5 Tocopheryl acetate CAS:7695 91 2 EINECS:231 710 N/A : NDA 0 Triethoxycaprylylsilane CAS:2943 75 1 EINECS:220 941 N/A : NDA 2 trimethylsiloxy silicate CAS:56275 01 5 N/A : NDA Trisiloxane CAS:107 51 7 EINECS:203 497 N/A : NDA 4 Water CAS:7732 18 5 EINECS:231 791 N/A : Classification criteria not met 2 Xanthan gum EINECS:234 394 2 N/A : NDA Zinc oxide CAS:1314 13 2 EINECS:215 222 5 3.5% : NDA N/A Designates that the chemical percentage of composition is not available as it is considered a trade secret. Section 4: First Aid Measures Description of first aid measures Inhalation Skin Eye Ingestion No specific treatment is necessary since this material is not likely to be hazardous by inhalation. If exposed to excessive levels of mists, remove to fresh air and get medical attention. For accidental and non therapeutic exposures, immediately flush skin with large amounts of water. Remove contaminated clothing. If irritation (redness, rash, blistering) develops, get medical attention. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. Call a physician or poison control center. Most important symptoms and effects, both acute and delayed Indication of any immediate medical attention and special treatment needed Other information Have the product container or label with you when calling a poison control center or doctor, or going for treatment. Section 5: Fire Fighting Measures Extinguishing media Suitable Extinguishing Media Water spray, carbon dioxide, dry chemical powder or appropriate foam for surrounding fire. Page 4 of 16

Unsuitable Extinguishing Media Special hazards arising from the substance or mixture Unusual Fire and Explosion Hazards Hazardous Combustion Products Advice for firefighters None known product is not flammable or combustible. As in any fire, wear self contained breathing apparatus and full protective gear to prevent contact with skin and eyes. Section 6 Accidental Release Measures Personal precautions, protective equipment and emergency procedures Personal Precautions Emergency Procedures Environmental precautions No special controls or personal protection required under conditions of intended use. In the event of bulk spills, wear suitable protective eyewear, clothing, protective boots and protective gloves. Refer to Section 8. No emergency procedures are expected to be necessary when used in accordance with product literature. Methods and material for containment and cleaning up Containment/Clean up Measures Section 7 Handling and Storage Precautions for safe handling Handling Contain spilled product. For small spills, add suitable absorbent material. Scoop up and place in an appropriate liquid tight container equipped with a tight cover for disposal. For large spills, dike spilled material or otherwise contain material to ensure runoff does not reach a waterway. Place spilled material in an appropriate, liquid tight container equipped with a tight cover for disposal. No special handling is required. Refer to Section 8. Use only in accordance with product literature. Conditions for safe storage, including any incompatibilities Storage Keep tightly closed and store in upright position. Store at room temperature 20 25ºC (68 77ºF). Section 8 Exposure Controls/Personal Protection Control parameters Exposure Limits/Guidelines BHT (128 37 0) Refer to the occupational exposure limits / guidelines for the individual product components. Exposure Limits/Guidelines Result ACGIH Canada Quebec NIOSH OSHA Other Agency Information STELs 10 mg/m3 STEV TWAs 2 mg/m3 TWA (inhalable fraction and vapor) 10 mg/m3 TWA 15 mg/m3 TWA (mist, Page 5 of 16

Glycerin (56 81 5) Benzyl alcohol (100 51 6) PEG 8 (25322 68 3) Silica (7631 86 9) Zinc oxide (1314 13 2) Titanium dioxide (13463 67 7) TWAs 10 mg/m3 TWAEV (mist) total particulate); 5 mg/m3 TWA (mist, respirable fraction) TWAs 10 ppm TWA TWAs 10 mg/m3 TWA (MW>200, aerosol) TWAs 6 mg/m3 TWA STELs TWAs 10 mg/m3 STEL (respirable fraction) 2 mg/m3 TWA (respirable fraction) Ceilings TWAs 10 mg/m3 TWA 10 mg/m3 STEV (fume) 10 mg/m3 TWAEV (containing no Asbestos and <1% Crystalline silica, total dust); 5 mg/m3 TWAEV (fume) 10 mg/m3 TWAEV (containing no Asbestos and <1% Crystalline silica, total dust) 10 mg/m3 STEL (fume) 5 mg/m3 TWA (dust and fume) 15 mg/m3 Ceiling (dust) 5 mg/m3 TWA (fume); 15 mg/m3 TWA (total dust); 5 mg/m3 TWA (respirable fraction) 15 mg/m3 TWA (total dust) Exposure Control Notations ACGIH Titanium dioxide (13463 67 7): Carcinogens: (A4 Not Classifiable as a Human Carcinogen) BHT (128 37 0): Carcinogens: (A4 Not Classifiable as a Human Carcinogen) Exposure controls Engineering Measures/Controls Good general ventilation should be used. Ventilation rates should be matched to conditions. If applicable, use process enclosures, local exhaust ventilation, or other engineering controls to maintain airborne levels below recommended exposure limits. If exposure limits have not been established, maintain airborne levels to an acceptable level. Personal Protective Equipment Respiratory No respiratory protection required during normal handling. Eye/Face Avoid contact with the eye. No special controls or personal protection required under conditions of intended use. In the event of a bulk spill, appropriate eye protection should be worn. Hands Gloves are not required under normal handling conditions. Skin/Body Environmental Exposure Controls No special personal protection required under conditions of intended use. In the event of a bulk spill, wear appropriate protective clothing. Section 9 Physical and Chemical Properties Information on Physical and Chemical Properties Material Description Physical Form Liquid Appearance/Description Smooth, thick off white lotion. Color Off white Odor No odor. Page 6 of 16

Odor Threshold Not relevant General Properties Boiling Point No data available Melting Point/Freezing Point Not relevant Decomposition Temperature Not relevant ph 6.5 to 8.5 Specific Gravity/Relative Density 1.04 to 1.07 Water=1 Water Solubility Miscible Viscosity Not relevant Volatility Vapor Pressure Not relevant Vapor Density Not relevant Evaporation Rate Not relevant Flammability Flash Point Not relevant UEL Not relevant LEL Not relevant Autoignition Not relevant Burning Time Not relevant Flammability (solid, gas) Not relevant Environmental Octanol/Water Partition coefficient No data available Section 10: Stability and Reactivity Reactivity Chemical stability No dangerous reactions known. Stable under normal temperatures and pressures. Possibility of hazardous reactions Conditions to avoid Extreme heat or cold. Do not freeze. Incompatible materials None. Hazardous decomposition products None expected. Section 11 Toxicological Information Information on toxicological effects Other Material Information Toxicological information refers to raw materials only. Concentrations and toxicological effects are substantially reduced in the product. Components Titanium dioxide (3.7%) Zinc oxide (3.5%) 13463 67 7 1314 13 2 Irritation: Skin Human 300 µg 3 Day(s) Intermittent Mild irritation; Multi dose Toxicity: Inhalation Rat TCLo 10 mg/m³ 6 Hour(s) 13 Week(s) Intermittent; Lungs, Thorax, or Respiration:Fibrosis (interstitial); Lungs, Thorax, or Respiration:Other changes; Biochemical:Metabolism (intermediary):effect on inflammation or mediation of inflammation; Tumorigen / Carcinogen: Inhalation Rat 10 mg/m³ 18 Hour(s) 2 Year(s) Intermittent; Tumorigenic:Carcinogenic by RTECS criteria; Lungs, Thorax, or Respiration:Tumors Acute Toxicity: Ingestion/Oral Rat LDLo >8437 mg/kg; Inhalation Rat TCLo 25 mg/m³ 3 Hour(s); Lungs, Thorax, or Respiration:Other changes; Biochemical:Enzyme inhibition, induction, or change in blood or tissue levels:phosphatases; Biochemical:Metabolism (intermediary):effect on inflammation or mediation of inflammation; Irritation: Eye Rabbit 500 mg 24 Hour(s) Mild irritation; Skin Rabbit 500 mg 24 Hour(s) Mild irritation Page 7 of 16

GHS Properties Respiratory sensitization Serious eye damage/irritation Acute toxicity Aspiration Hazard Carcinogenicity Skin corrosion/irritation Skin sensitization STOT RE STOT SE Toxicity for Reproduction Germ Cell Mutagenicity Potential Health Effects Inhalation Acute (Immediate) Chronic (Delayed) Skin Acute (Immediate) Chronic (Delayed) Eye Acute (Immediate) Chronic (Delayed) Ingestion Acute (Immediate) Chronic (Delayed) Classification Classification criteria not met Eye Mild Irritation 2B Classification criteria not met Classification criteria not met Classification criteria not met Classification criteria not met Classification criteria not met Classification criteria not met Classification criteria not met Classification criteria not met Classification criteria not met Under normal conditions of use, no health effects are expected. Under normal conditions of use, no health effects are expected. Under normal conditions of use, no health effects are expected. Under normal conditions of use, no health effects are expected. Causes mild eye irritation with direct contact to eye. Under normal conditions of use, no health effects are expected. Under normal conditions of use, no health effects are expected. Under normal conditions of use, no health effects are expected. Carcinogenic Effects CAS IARC NTP Carbomer 9003 01 4 Group 3 Not Classifiable Cholesterol 57 88 5 Group 3 Not Classifiable L Ascorbic acid 50 81 7 Evidence of Carcinogenicity BHT 128 37 0 Group 3 Not Classifiable Evidence of Carcinogenicity Polymethyl methacrylate 9011 14 7 Group 3 Not Classifiable Benzyl alcohol 100 51 6 Evidence of Carcinogenicity Silica 7631 86 9 Group 3 Not Classifiable Titanium dioxide 13463 67 7 Group 2B Possible Carcinogen Evidence of Carcinogenicity Section 12 Ecological Information Toxicity Page 8 of 16

This material has not been tested for environmental effects. Persistence and degradability Bioaccumulative potential Mobility in Soil Other adverse effects Section 13 Disposal Considerations Waste treatment methods Product waste Waste characterizations and compliance with applicable laws are the responsibility solely of the waste generator. Packaging waste Dispose of content and/or container in accordance with local, regional, national, and/or international regulations. Section 14 Transport Information UN number UN proper shipping name Transport hazard class (es) Packing group DOT Not Applicable Not Regulated Not Applicable Not Applicable TDG Not Applicable Not Regulated Not Applicable Not Applicable IMO/IMDG Not Applicable Not Regulated Not Applicable Not Applicable IATA/ICAO Not Applicable Not Regulated Not Applicable Not Applicable Environmental hazards Special precautions for user Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code Section 15 Regulatory Information Safety, health and environmental regulations/legislation specific for the substance or mixture SARA Hazard Classifications Inventory Component CAS Canada DSL Canada NDSL EU EINECS EU ELNICS TSCA Butylene glycol 107 88 0 Yes No Yes No Yes Behenyl alcohol 661 19 8 Yes No Yes No Yes Methylisothiazolinone 2682 20 4 Yes No Yes No Yes Styrene/Acrylates Copolymer 25034 86 0 Yes No No No Yes Arachidyl alcohol 629 96 9 Yes No Yes No Yes butyloctyl salicylate 190085 41 7 No No No Yes No Page 9 of 16

Cetyl Dimethicone 191044 49 2 Yes No No No Yes Dimethicone 63148 62 9 Yes No No No Yes PEG 100 stearate 9004 99 3 Yes No No No Yes isohexadecane 4390 04 9 Yes No Yes No Yes Polyhydroxystearic acid Dimethicone PEG 8 Laurate 27924 99 8 Yes No No No Yes 35179 86 3 Yes No No No No Trisiloxane 107 51 7 Yes No Yes No Yes PEG 8 25322 68 3 Yes No No No Yes Silica 7631 86 9 Yes No Yes No Yes Polysorbate 60 9005 67 8 Yes No No No Yes Titanium dioxide 13463 67 7 Yes No Yes No Yes trimethylsiloxy silicate 56275 01 5 No Yes No No Yes Zinc oxide 1314 13 2 Yes No Yes No Yes Canada Labor Canada List of Prohibited and Restricted Cosmetic Ingredients (The Cosmetic Ingredient Hotlist) Restricted (Permitted at Methylisothiazolinone 2682 20 4 concentrations <=0.01% for use as a preservative) Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 Titanium dioxide 13463 67 7 Zinc oxide 1314 13 2 Silica 7631 86 9 Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 Canada WHMIS Classifications of Substances Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 D2A (In certain cases, this Page 10 of 16

classification does not apply. For more information, consult the section Substance Specific Titanium dioxide 13463 67 7 Issues Titanium dioxide, mixture containing on Health Canada's WHMIS Division website.) Uncontrolled product Zinc oxide 1314 13 2 according to WHMIS classification criteria Uncontrolled product Silica 7631 86 9 according to WHMIS classification criteria Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 Uncontrolled product PEG 100 stearate 9004 99 3 according to WHMIS classification criteria isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 Canada WHMIS Ingredient Disclosure List Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 0.1 % Trisiloxane 107 51 7 PEG 8 25322 68 3 Titanium dioxide 13463 67 7 Zinc oxide 1314 13 2 1 % Silica 7631 86 9 1 % Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 1 % isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 Europe Page 11 of 16

Other EU CLP (1272/2008) Annex VI Table 3.2 Classification Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 Titanium dioxide 13463 67 7 Zinc oxide 1314 13 2 N; R50 53 Silica 7631 86 9 Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 R53 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 EU CLP (1272/2008) Annex VI Table 3.2 Labelling Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 Titanium dioxide 13463 67 7 Zinc oxide 1314 13 2 N R:50/53 S:60 61 Silica 7631 86 9 Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 R:53 S:61 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 EU CLP (1272/2008) Annex VI Table 3.2 Safety Phrases Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 Titanium dioxide 13463 67 7 Page 12 of 16

Zinc oxide 1314 13 2 S:60 61 Silica 7631 86 9 Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 S:61 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 United States Environment U.S. CERCLA/SARA Section 313 Emission Reporting Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 Titanium dioxide 13463 67 7 Zinc oxide 1314 13 2 1.0 % de minimis concentration (listed under Chemical Category N982) Silica 7631 86 9 Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 U.S. RCRA (Resource Conservation & Recovery Act) List for Hazardous Constituents Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 Titanium dioxide 13463 67 7 Zinc oxide 1314 13 2 Silica 7631 86 9 Page 13 of 16

Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 U.S. RCRA (Resource Conservation & Recovery Act) TSD Facilities Ground Water Monitoring Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 Titanium dioxide 13463 67 7 Zinc oxide 1314 13 2 Silica 7631 86 9 Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 United States California Environment U.S. California Proposition 65 Carcinogens List Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 carcinogen, initial date 9/2/11 Titanium dioxide 13463 67 7 (airborne, unbound particles of respirable size) Zinc oxide 1314 13 2 Silica 7631 86 9 Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Page 14 of 16

Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 U.S. California Proposition 65 Developmental Toxicity Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 Titanium dioxide 13463 67 7 Zinc oxide 1314 13 2 Silica 7631 86 9 Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 U.S. California Proposition 65 Reproductive Toxicity Female Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 Titanium dioxide 13463 67 7 Zinc oxide 1314 13 2 Silica 7631 86 9 Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Page 15 of 16

Dimethicone PEG 8 Laurate 35179 86 3 U.S. California Proposition 65 Reproductive Toxicity Male Methylisothiazolinone 2682 20 4 Butylene glycol 107 88 0 Trisiloxane 107 51 7 PEG 8 25322 68 3 Titanium dioxide 13463 67 7 Zinc oxide 1314 13 2 Silica 7631 86 9 Polysorbate 60 9005 67 8 Polyhydroxystearic acid 27924 99 8 Styrene/Acrylates Copolymer 25034 86 0 Arachidyl alcohol 629 96 9 Behenyl alcohol 661 19 8 PEG 100 stearate 9004 99 3 isohexadecane 4390 04 9 butyloctyl salicylate 190085 41 7 trimethylsiloxy silicate 56275 01 5 Cetyl Dimethicone 191044 49 2 Dimethicone 63148 62 9 Dimethicone PEG 8 Laurate 35179 86 3 Section 16 Other Information Revision Date Last Revision Date Preparation Date Disclaimer/Statement of Liability 25/September/2015 25/September/2015 25/September/2015 To the best of our knowledge, the information contained herein is accurate. However, neither Valeant Pharmaceuticals International, Inc. nor any of its subsidiaries assumes any liability whatsoever for the accuracy or completeness of the information contained herein. Final determination of suitability of any material is the sole responsibility of the user. All materials may present unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot guarantee that these are the only hazards that exist. NO WARRANTY, EXPRESS OR IMPLIED, OF MERCHANTABILITY, FITNESS OR OTHERWISE IS MADE. In no event shall Valeant Pharmaceuticals International, Inc. or any of its subsidiaries be liable for any special, incidental or consequential damages. Page 16 of 16